Jay R. Venkatesan
Board Member
Elicio Therapeutics, Inc. (ELTX)Board Member
Exicure, Inc. (XCUR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Elicio Therapeutics, Inc. (ELTX) | former Chief Executive Officer, President, and Chairman of the Angion Board | $243,944 | $2,429,275 |
| 2022 | Elicio Therapeutics, Inc. (ELTX) | former Chief Executive Officer, President, and Chairman of the Angion Board | $608,000 | $1,518,849 |
| 2021 | Elicio Therapeutics, Inc. (ELTX) | M.D., President and Chief Executive Officer and Chairman of the Board | $587,100 | $2,539,199 |
| 2020 | Elicio Therapeutics, Inc. (ELTX) | M.D., President and Chief Executive Officer and Chairman of the Board | $570,000 | $1,394,398 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.